Form 4 for ALT Altimmune, Inc.
Accepted 2022-02-03 00:00:00 ET · period of report 2022-01-31 · accession 0001104659-22-011517 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-03 | 2022-02-01 | ALT | Roberts M Scot | CSO | F - Tax | $7.98 | -2,183 | 17.7K | -11% | -$17.4K |
| D | 2022-02-03 | 2022-02-01 | ALT | Roberts M Scot | CSO | M - OptEx | $0.00 | +6,166 | 19.9K | +45% | $0 |
| D | 2022-02-03 | 2022-01-31 | ALT | Roberts M Scot | CSO | A - Grant | $6.86 | +2,106 | 13.7K | +18% | +$14.4K |
| DM | 2022-02-03 | 2022-02-02 | ALT | Roberts M Scot | CSO | A - Grant | $0.00 | +122.7K | 31.1K | New | $0 |
| D | 2022-02-03 | 2022-02-01 | ALT | Roberts M Scot | CSO | M - OptEx | $0.00 | -6,166 | 18.5K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2022-02-01 | F | D | 2,183 | $7.98 | 17,700 | D | — | — | |
| 2 | Common | Common Stock, par value $0.0001 | 2022-02-01 | M | A | 6,166 | $0.00 | 19,883 | D | — | — | (F3) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. |
| 3 | Common | Common Stock, par value $0.0001 | 2022-01-31 | A | A | 2,106 | $6.86 | 13,717 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 31, 2022. |
| 4 | Derivative | Stock Options (option to buy) | 2022-02-02 | A | A | 91,600 | $0.00 | 91,600 | D | $7.53 · — to 2032-02-02 | 91,600 Common Stock, par value $0.0001 | (F6) Twenty-five percent of the shares underlying the option become vested and exercisable on February 2, 2023 and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following February 2, 2023, subject to the reporting person's continued service through the applicable vesting date. |
| 5 | Derivative | Restricted Stock Units | 2022-02-01 | M | D | 6,166 | $0.00 | 18,498 | D | — · — to — | 6,166 Common Stock, par value $0.0001 | (F3) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F5) The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |
| 6 | Derivative | Restricted Stock Units | 2022-02-02 | A | A | 31,100 | $0.00 | 31,100 | D | — · — to — | 31,100 Common Stock, par value $0.0001 | (F3) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F7) The RSUs become vested and exercisable in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. |